RAPID POINT OF CARE DIAGNOSTIC TEST FOR HISTOPLASMOSIS
$299,998N43FY2020AINIH
Zymeron Corporation, Durham NC
Investigators
Abstract
To develop a diagnostic for histoplasmosis infections.
View original record on NIH RePORTER →Zymeron Corporation, Durham NC
To develop a diagnostic for histoplasmosis infections.
View original record on NIH RePORTER →